Author

L. Morey

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Research Focus:chromatin & epigenetic regulation· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Assay:DNA methylation· 1

Frequent Co-Authors

H. L. Chan· 2 shared A. Aubert· 1 shared A. Carr· 1 shared A. Jartseva· 1 shared A. Ponjavic· 1 shared B. Hendrich· 1 shared C. Banuelos· 1 shared C. Premer· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

H. L. Chan

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.

L. Caeiro, Y. Nakata, R. L. Borges, L. Garcia-Martinez, C. Banuelos, S. Stransky, H. L. Chan, J. Brabson, D. Dominguez, Y. Zhang, P. W. Lewis, S. A. Benitah, L. Cimmino, D. Bilbao, S. Sidoli, , L. Morey

This study shows that H3K36M mutations in HNSCC create a therapeutic window by altering H3K27me3 levels, making tumors sensitive to PARP1/2 inhibitors or their combination with H3K27me3-upregulating agents.

bioRxiv · Nov 6, 2023Cancer Biology

HssS activation by membrane heme defines a paradigm for 2-component system signaling in Staphylococcus aureus.

D. Lechardeur, V. Saillant, L. Morey, D. Lipuma, P. Boëton, P. Arnoux

This study identifies how heme binds to the HssS sensor in Staphylococcus aureus, triggering a signaling cascade that activates heme efflux to prevent toxicity.

bioRxiv · Nov 3, 2022 · PreprintMicrobiology

Live-cell 3D single-molecule tracking reveals how NuRD modulates enhancer dynamics

S. Basu, O. Shukron, D. Hall, P. Parruto, A. Ponjavic, D. Shah, W. Boucher, D. Lando, W. Zhang, N. Reynolds, L. H. Sober, A. Jartseva, R. Ragheb, X. Ma, J. Cramard, , E. D. Laue

This study uses live-cell 3D single-molecule tracking to show that the NuRD complex decompacts chromatin and alters enhancer dynamics by increasing their movement and reducing time in a fast-diffusing state.

bioRxiv · Apr 3, 2020 · PreprintCell Biology

PDGFRA Defines the Mesenchymal Stem Cell Kaposi’s Sarcoma Progenitors by Enabling KSHV Oncogenesis in an Angiogenic Environment

J. Naipauer, S. Rosario, S. Gupta, C. Premer, O. Mendez, M. Schlesinger, V. Ponzinibbio, V. Jain, L. Gay, R. Renne, H. L. Chan, L. Morey, D. Salyakina, M. Abba, S. Williams, , E. Mesri

The paper identifies PDGFRA+ bone marrow-derived mesenchymal stem cells as Kaposi’s sarcoma progenitors and shows pro-angiogenic conditions enable KSHV oncogenesis through epigenetic de-repression.

bioRxiv · Oct 2, 2019Cancer Biology